Table 1.
Prevalence of comorbidities in ageing PLWH (when available comorbidities in age‐matched uninfected individuals are presented in italic)
| Country data source | Population | Mean age, years | Diabetes, % | Dyslipidaemia, % | Hypertension, % | Renal disease, % | CVD disease, % | Bone disorder, % | Respiratory disorder, % | Cancer, % |
|---|---|---|---|---|---|---|---|---|---|---|
| Brazil 28 | 451 PLWH | 58 | 14.9 | 26.7 | 6.7 | 3.1 | ||||
| 3 HIV centres | ||||||||||
| Brazil 29 | 208 PLWH | 57 | 22.6 | 62.0 | 16.8 | 9.6 | 52.9 | 10.6 | ||
| Brazilian cohort | 208 HIV neg | 57 | 28.4 | 69.7 | 6.7 | 12.5 | 10.1 | 6.3 | ||
| USA 30 | 2359 PLWH | 71 | 25.9 | 35.7 | 47.9 | 20.9 | 20.3 | 31.3 | ||
| Medicare | 2 mio HIV neg | 76 | 24.1 | 46.9 | 59.4 | 19.6 | 21.4 | 26.3 | ||
| Portugal 31 | 401 PLWH | 59 | 13.5 | 60.8 | 39.7 | 8.0 | 5.7 | 9.0 | 8.0 | |
| 7 HIV centres | ||||||||||
| France 32 | 16436 PLWH | 56 | 9.1 | 58.3 | 21.0 | 4.5 | 10.8 | 6.4 | 12.3 | |
| Dat'AIDS cohort | 572 PLWH | 78 | 22.0 | 60.8 | 43.5 | 29.4 | 23.4 | 12.6 | 22.9 | |
| France 19 | 10318 PLWH | 56 | 9.3 | 23.6 | 21.0 | 9.6 | 9.0 | 14.6 | ||
| 11 HIV centres | ||||||||||
| Europe 33 | 3797 | 50 to 60 | 8.0 | 79.5 | 79.0 | 7.0 | 7.0 | |||
| EuroSIDA cohorta |
PLWH 1837 PLWH |
≥60 | 17.0 | 84.0 | 84.0 | 23.0 | 15.5 | |||
| Italy 34 | 965 PLWH | 65 to 74 | 27.5 | 70.0 | 60.8 | 17.1 | 16.9 | 6.6 | ||
| GEPPO cohort | 224 HIV neg | 65 to 74 | 22.3 | 57.8 | 66.5 | 5.0 | 18.3 | 9.1 | ||
|
293 PLWH |
≥75 | 31.2 | 74.6 | 71.8 | 26.0 | 29.2 | 9.8 | |||
| 91 HIV neg | ≥75 | 15.4 | 50.0 | 67.0 | 10.0 | 30.8 | 18.9 | |||
| Switzerland 35 | 2233 PLWH | 50 to 64 | 7.0 | 69.8 | ||||||
| SHCS cohort | 450 PLWH | ≥65 | 16.2 | 78.9 |
CVD, cardiovascular; mio, million.
a
Study period 2014.